Content about Schiff Nutrition

April 8, 2013
CRN signs six new members, including Reckitt Benckiser

The Council for Responsible Nutrition on Monday named six new members, including Aurora Algae, Nature’s Sources, Reckitt Benckiser, Sirio Pharma, Watson and international member JJ Health.

January 15, 2013
Wellness surge, regulations create healthy growth

Interest in vitamins, minerals and supplements as a viable consumer product with strong profit-bearing potential has got to be at an all-time high right now, judging from the number of merger and acquisition deals scrolling across the latest finance news feeds.

November 26, 2012
Reckitt Benckiser pursuit of Schiff Nutrition a success; companies sign definitive merger agreement

Reckitt Benckiser successfully wrapped up its pursuit of Schiff Nutrition on Friday with the signing of a definitive merger agreement in a deal valued at $1.4 billion. Bayer officially relinquished its proposed acquisition on the same day.

November 20, 2012
Report: Bayer will not raise offer for Schiff Nutrition as negotiations continue

Bayer will not be raising its offer for Schiff Nutrition to match or exceed last week's bid from Reckitt Benckiser, Reuters reported Tuesday morning.

November 16, 2012
Reckitt Benckiser ups the ante for Schiff business with a 23.5% premium to Bayer buyout offer

The battle for Schiff Nutrition is on. Reckitt Benckiser on Friday commenced its previously announced tender offer to acquire all of the outstanding shares of Schiff Nutrition — a provider of branded vitamins, nutrition supplements and nutrition bars in the United States and elsewhere — for $42 per share in cash, or approximately $1.4 billion.

November 16, 2012
Reckitt Benckiser vs. Bayer: Having VMS in the product portfolio good insurance for future growth

Reckitt Benckiser on Friday made an offer to acquire all of the outstanding shares of VMS maker Schiff Nutrition for $42 per share in cash, or approximately $1.4 billion — a premium of 23.5% more than the $34 per share offer Bayer HealthCare announced Oct. 30.

July 22, 2011
Schiff: Stop the BOGO promo

Enough is enough. That’s what Schiff Nutrition director, president and CEO Tarang Amin told analysts during a conference call Thursday — only four months into his tenure — regarding the predominant industry practice of funding buy-one-get-one promotions for glucosamine and chondroitin supplements.

July 7, 2011
Steeves-Kiss joins Schiff as SVP, chief marketing officer

Schiff Nutrition on Wednesday named Jennifer Steeves-Kiss SVP and chief marketing officer. Steeves-Kiss joins Schiff from Procter & Gamble, where for almost two decades she helped build premium brands.

June 20, 2011
Schiff looks to probiotics acquisition for growth

Schiff Nutrition president and CEO Tarang Amin promised to infuse some new energy into the company with his appointment earlier this spring, and he wasted no time with the Schiff acquisition of two probiotic brands — Sustenex and Digestive Advantage — in June. 


June 2, 2011
Schiff buys into probiotic business

Schiff Nutrition on Tuesday announced its $40 million acquisition from Ganeden Biotech of the worldwide exclusive rights to use the probiotic technology GanedenBC30 in the over-the-counter and dietary supplement space, along with the brands Sustenex and Digestive Advantage, under which GanedenBC30 currently is sold.

© 2013 Drug Store News. All Rights Reserved.